We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Current Antiretroviral Treatment Among People With Human Immunodeficiency Virus in the United States: Findings from the Centers for AIDS Research Network of Integrated Clinic Systems Cohort.
- Authors
Ma, Jimmy; Nance, Robin M; Delaney, Joseph A C; Whitney, Bridget M; Bamford, Laura; Gravett, Ronnie M; Moore, Richard D; Napravnik, Sonia; Mayer, Kenneth H; Jacobson, Jeffrey M; Christopoulos, Katerina; Burkholder, Greer A; Keruly, Jeanne; Eron, Joseph J; Martin, Jeffrey; Cachay, Edward R; Saag, Michael S; Crane, Heidi M; Kitahata, Mari M
- Abstract
Among 14 049 people with human immunodeficiency virus in care in 2019–2020, 96% were treated with antiretroviral therapy (ART). Current antiretroviral treatment patterns highlight high uptake of guideline-recommended ART regimens including second-generation integrase strand transfer inhibitors (dolutegravir and bictegravir) and tenofovir alafenamide, especially in antiretroviral-naive individuals initiating ART.
- Subjects
UNITED States; HIV infection risk factors; HIV infections; HIV integrase inhibitors; TENOFOVIR; CROSS-sectional method; ANTIRETROVIRAL agents; HEALTH outcome assessment; REGRESSION analysis; DESCRIPTIVE statistics; DATA analysis software; LONGITUDINAL method
- Publication
Clinical Infectious Diseases, 2022, Vol 75, Issue 4, p715
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciac086